| human | Q5 |
| P1960 | Google Scholar author ID | 2OOv0DEAAAAJ |
| P691 | NL CR AUT ID | nlk20050166518 |
| P6023 | ResearchGate contributions ID | 39897121 |
| P1153 | Scopus author ID | 26643455500 |
| P214 | VIAF ID | 84870894 |
| P166 | award received | Fellow of the American Association for the Advancement of Science | Q5442484 |
| P108 | employer | University of Alabama at Birmingham | Q1472663 |
| P734 | family name | Briles | Q37021332 |
| Briles | Q37021332 | ||
| Briles | Q37021332 | ||
| P735 | given name | David | Q18057751 |
| David | Q18057751 | ||
| P106 | occupation | microbiologist | Q3779582 |
| P21 | sex or gender | male | Q6581097 |
| Q28084760 | A molecular mucosal adjuvant to enhance immunity against pneumococcal infection in the elderly |
| Q36313904 | Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins |
| Q34530684 | Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae |
| Q35717991 | CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopes |
| Q30433651 | Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence |
| Q35783885 | Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. |
| Q35005112 | Decrease in penicillin susceptibility due to heat shock protein ClpL in Streptococcus pneumoniae. |
| Q35689099 | Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. |
| Q36933011 | Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae |
| Q33798317 | Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage |
| Q36933015 | Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers |
| Q33617169 | Effect of apolactoferrin on experimental pneumococcal otitis media |
| Q33665793 | Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1. |
| Q36228991 | Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface |
| Q34854559 | Effects of zinc deficiency and pneumococcal surface protein a immunization on zinc status and the risk of severe infection in mice |
| Q24656785 | Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniae |
| Q34889616 | Ethanol-induced alcohol dehydrogenase E (AdhE) potentiates pneumolysin in Streptococcus pneumoniae. |
| Q35021099 | Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins |
| Q34840451 | Evolution and virulence of serogroup 6 pneumococci on a global scale |
| Q33394397 | Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A. |
| Q33535951 | Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A. |
| Q33877129 | Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection |
| Q35165637 | Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12. |
| Q33899358 | Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC. |
| Q28743311 | Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring |
| Q34334220 | Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence |
| Q34134769 | Mouse, but not human, ApoB-100 lipoprotein cholesterol is a potent innate inhibitor of Streptococcus pneumoniae pneumolysin |
| Q36087567 | Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection |
| Q35924482 | Nontypeable pneumococci can be divided into multiple cps types, including one type expressing the novel gene pspK |
| Q33717128 | Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection |
| Q35704899 | Protection of the elderly from pneumococcal pneumonia with a protein-based vaccine? |
| Q36313963 | PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation |
| Q34618641 | PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in Japan |
| Q36017785 | PspA family distribution, unlike capsular serotype, remains unaltered following introduction of the heptavalent pneumococcal conjugate vaccine |
| Q34713678 | Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model |
| Q36009308 | Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae |
| Q35165275 | Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae |
| Q34121334 | Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae |
| Q35075775 | Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin |
| Q35075156 | Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media |
| Q36030999 | Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice |
| Q35066962 | Streptococcus pneumoniae isolates from middle ear fluid and nasopharynx of children with acute otitis media exhibit phase variation |
| Q27645143 | Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism |
| Q35808789 | The Effects of CFTR and Mucoid Phenotype on Susceptibility and Innate Immune Responses in a Mouse Model of Pneumococcal Lung Disease. |
| Q35328544 | The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia |
Search more.